Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a randomized placebo-controlled trial

It is unclear if genetic variants affect smoking cessation treatment response. This study tested whether variants in the cholinergic receptor nicotinic alpha 5 subunit (CHRNA5) predict response to smoking cessation medication by directly comparing two most effective smoking cessation pharmacotherapi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Pharmacol Ther
Autori principali: Chen, Li-Shiun, Baker, Timothy B., Miller, J. Philip, Bray, Michael, Smock, Nina, Chen, Jingling, Stoneking, Faith, Culverhouse, Robert C., Saccone, Nancy L., Amos, Christopher I., Carney, Robert M., Jorenby, Douglas E., Bierut, Laura J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993015/
https://ncbi.nlm.nih.gov/pubmed/32602170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1971
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi